Neonatal Neurologic Intensive Care Network of China

NCT02544100 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2025-09-05

No results posted yet for this study

Summary

The purpose of this study is to create a neonatal neurologic biological big data center named Neonatal Neurologic Intensive Care Network in China with neonatal systematic information, biological samples and genomics \& genetic data on neonates born with neonatal severe encephalopathy. It also can predict brain injury as cerebral function monitoring through big data and recommend appropriate treatment. In addition, the following samples will be collected in a bio-bank in for future studies: blood, urine, and cerebrospinal fluid (CSF) samples.

Conditions

  • Neonatal Encephalopathy
  • Suspected Neonatal Encephalopathy

Interventions

OTHER

Database Entry/Biospecimen Collection

blood, urine, CFS samples and medical data collected

Sponsors & Collaborators

  • Xiamen Children's Hospital, Fujian of China

    collaborator OTHER
  • Maternal and Child Health Hospital of Guangxi Zhuang Autonomous Region

    collaborator OTHER
  • Guangzhou Women and Children's Medical Center

    collaborator OTHER
  • Yuying Children's Hospital of Wenzhou Medical University, Zhejiang of China

    collaborator UNKNOWN
  • Maternal and Child Health Hospital of Hubei Province

    collaborator OTHER
  • The People's Hospital of Dehong Autonomous Prefecture

    collaborator OTHER
  • Guangzhou Medical University

    collaborator OTHER
  • Nanfang Hospital, Southern Medical University

    collaborator OTHER
  • Children's Hospital of Fudan University

    lead OTHER

Principal Investigators

  • Wenhao Zhou, Doctor · Children's Hospital of Fudan University

Eligibility

Max Age
28 Days
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-09-01
Primary Completion
2025-12-30
Completion
2025-12-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02544100 on ClinicalTrials.gov